Celltrion holdings Nasdaq

South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...

South Korea’s top four financial holding companies – Shinhan, KB, Hana and Woori – reported stellar earnings for the first quarter...

South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply contracts for its flags...

Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...

South Korea’s Constitutional Court permanently removed President Yoon Suk Yeol from office on Friday, making him the country’s second pr...

South Korea’s Constitutional Court on Friday will give its ruling on President Yoon Suk Yeol, who was impeached in December for declaring mart...

South Korea’s chemical-to-defense conglomerate Hanwha Group Chairman Kim Seung-youn will hand over half of his holdings in the conglomerate&rs...

South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to autoimmune disease t...

South Korea’s National Pension Service (NPS), the world’s third-largest pension fund, has agreed to buy a stake in Australian asset mana...

South Korea’s leading biosimilar drug developer Celltrion Inc. announced on Friday a plan to cancel $140 million worth of treasury shares to i...

Hanwha Energy Corp., wholly owned by Hanwha Group Chairman Kim Seung-youn’s three sons, has embarked on the process of going public – a ...

Webtoon Entertainment Inc., the Nasdaq-listed storytelling platform operator under South Korea’s internet giant Naver Corp., is set to expand ...

Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...

Affinity Equity Partners and Singapore’s sovereign wealth fund GIC have sold their entire stake in Kyobo Life Insurance Co., exiting from thei...

LG Electronics Inc. posted its largest-ever sales in India in 2024, providing a boost to the planned initial public offering of its Indian unit this...

Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...

Meritz Financial Group Inc., once a medium-sized financial service firm in South Korea, has become the second-most valuable publicly traded financia...

Global private equity firm KKR & Co. Inc. has succeeded in cashing out of its stake in HD Hyundai Marine Solution Co. for 295 billion won ($206 ...

Meritz Financial Group Inc. has reported its best-ever net profit for last year thanks to handsome gains from investments by its insurance and secur...

KB Financial Group Inc., South Korea’s largest financial holding group, will spend nearly 1.8 trillion won ($1.2 billion) to boost shareholder...

South Korea’s leading biosimilar drug developer Celltrion Inc.'s Vegzelma, a cancer drug referencing global biopharma Roche’s Avastin, h...

South Korea’s top four financial holding firms are estimated to have posted their highest-ever profits in 2024, driven by hefty interest incom...

Sono Hospitality Group, South Korea’s top resort operator, has vowed to more actively horn in on the business of T'way Air Co., portending a p...

Korea Investment Holdings Co. said on Thursday it was upgraded by three notches from B to A in the MSCI ESG rating this year.The MSCI ESG rating is ...

SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...

K Wave Media Ltd., an umbrella entity of South Korean entertainment companies, is set to go public on the Nasdaq next month in a bid to raise money ...

South Korea's Mirae Asset Global Investments said on Sunday it invested $200 million in Essex Solutions, a US magnet wire manufacturing affiliate un...

South Korea’s two leading drugmakers, Celltrion Inc. and Samsung Bioepis Co., have achieved a significant milestone in the European biosimilar...

South Korea’s steel-to-battery materials conglomerate POSCO Group on Monday unveiled a spate of corporate value-up measures, including a highe...

South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...